Cargando…
Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients
BACKGROUND: It is popularly believed that myasthenia gravis (MG) patients show acetylcholine receptor antibody (AChRAb) production associated with the thymus (germinal centers, approximately 80%). It has been suggested that thymectomy can remove the area of autoantibody production. This study aimed...
Autores principales: | Yoshida, Mitsuteru, Kondo, Kazuya, Matsui, Naoko, Izumi, Yuishinn, Bando, Yoshimi, Yokoishi, Michihiro, Kajiura, Kouichirou, Tangoku, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535042/ https://www.ncbi.nlm.nih.gov/pubmed/33017427 http://dx.doi.org/10.1371/journal.pone.0239756 |
Ejemplares similares
-
Outcomes after Thymectomy in Patients with Thymomatous Myasthenia Gravis
por: Rabiou, Sani, et al.
Publicado: (2022) -
Outcomes after thymectomy in non-thymomatous myasthenia gravis
por: Deboever, Nathaniel, et al.
Publicado: (2023) -
Subxiphoid completion thymectomy for refractory non-thymomatous myasthenia gravis
por: Ambrogi, Vincenzo, et al.
Publicado: (2020) -
Neurological outcomes of extended thymectomy for thymomatous myasthenia gravis: Subxiphoid vs. trans-sternal approaches
por: Zhu, Haoshuai, et al.
Publicado: (2022) -
Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
por: Barnett, Carolina, et al.
Publicado: (2014)